5 Language Tactics for Interviews | maslansky + partners
HR leader Nile Hull shares five language tactics for interviews, to help candidates use language thoughtfully and authentically.| maslansky+partners
When Zoe Glass was offered an intern position with us at m+p, she set out on a journey to understand what Language Strategy is all about. Here, she reflects on Stuart Hall, Kelly Osbourne, and what she learned about Language Strategy. The post Stuart Hall, Kelly Osbourne, and an Intern’s Take on Language Strategy appeared first on maslansky+partners.| maslansky+partners
If you’re in pharma communications and you think you’re in the business of “building trust,” you’re already behind. The rules have changed. And the stakes have never been higher. Lee Carter offers a wake-up call for those in pharma comms... and five key shifts to make to resonate with patients today. The post The Stakes Have Never Been Higher: Why Pharma Must Rethink Reputation—Now appeared first on maslansky+partners.| maslansky+partners
News that RFK Jr. will push to change the childhood vaccine schedule is putting intense new scrutiny on recommendations. When pharma responds with “trust the science” or appeals to authority of the CDC’s past recommendations, these messages often fall flat—or worse, appear dismissive. The post Why Pharma Must Rethink How It Explains the Vaccine Schedule—Not Just Defend It appeared first on maslansky+partners.| maslansky+partners
The Make America Healthy Again (MAHA) Commission has dropped its roadmap, and while the headlines sound like the usual policy fare (“modernize vaccines,” “expand injury research,” “re-evaluate childhood schedules”), what’s really happening is a communications earthquake. Ignore it, and you do so at your own peril. The post Vaccines, DTC, MAHA, and the Battle for Trust: Why Pharma Can’t Afford to Sit This One Out appeared first on maslansky+partners.| maslansky+partners
HR leader Nile Hull shares five language tactics for interviews, to help candidates use language thoughtfully and authentically.| maslansky+partners
In our work, we often hear “insights,” “learnings,” and “findings” used interchangeably. But are they really the same? And does it matter which one you use?| maslansky+partners
The controversy around American Eagle’s "good genes" jeans ad with Sydney Sweeney is not about denim or DNA. Lee Carter explores why the left and the right are so outraged.| maslansky+partners
Lee Carter shares four key steps pharma companies can take to engage more productively with the MAHA movement.| maslansky+partners
When it comes to corporate storytelling, companies can use the Goldilocks Principle to find the communication approach that's "just right."| maslansky+partners
In responding to the executive order on drug pricing, pharma companies have a chance to redefine their narrative.| maslansky+partners
People are angry. From DEI to tariffs and rising prices, companies need to understand how to respond & communicate in this new "age of rage."| maslansky+partners
Here are five corporate communication strategies that won't work in this evolving environment, and a guide on how to communicate successfully.| maslansky+partners
Democrats had a big challenge for this year's DNC: reintroduce Kamala Harris to the American public and redefine the party’s vision for the future. It was an opportunity to reframe and reshape their entire campaign narrative. We analyzed their strategic shifts in language and messaging—and how it transformed the voice of their campaign.| maslansky+partners
Partner Keith Yazmir shares insights on why selling innovation in technology is hard. This piece shares some provocative thoughts and insightful tips for tech marketers, to successfully drive adoption of innovative tech.| maslansky+partners
